Because SARS-CoV-2 constantly mutates to escape from the immune response, there is a reduction of neutralizing capacity of antibodies initially targeting the historical strain against emerging Variant
The epitope sequence was cited in Pastrana et al. (2005) Virology. 2005 Jul 5 337(2):365-72 [PMID: 15885736]. The epitope-specific antiserum was able to block infection of 293T cells with HPV58. The a
aSerum neutralization titers of pooled sera from six mice in each. Samples were taken 13 days post-inoculation, two weeks after first boost with 2 µg of RSPs (33 days post-inoculation) and two weeks a
